About Us
Company Overview
Our Leadership
Global Supply Chain
IP Protection
Quality & Compliance
Environmental, Health and Safety
Solutions and Services
Discovery Synthesis
GMP Services
Generic APIs
FTE Services
Regulatory Affairs
Peptide Synthesis Service
Oligonucleotide Synthesis
Cosmetic Peptides
GMP Manufacturing
GMP Production Capacity
GMP Compliance & Certification
Leuprorelin Acetate
Triptorelin Acetate
Triptorelin Pamoate
Goserelin Acetate
Cetrorelix Acetate
Exenatide Acetate
Semaglutide
Terlipressin Acetate
Teduglutide
Linaclotide
Difelikefalin
Resources Center
FAQ
White Paper
Video
News
Company News
Blog
Careers
Contact Us
Catalog Peptides
US Operation
WHAT ARE YOU LOOKING FOR?
Home
About Us
About Us
Company Overview
Our Leadership
Global Supply Chain
IP Protection
Quality & Compliance
Environmental, Health and Safety
Solutions and Services
Solutions and Services
Discovery Synthesis
GMP Services
Generic APIs
FTE Services
Regulatory Affairs
Resources Center
Resources Center
FAQ
White Paper
Video
News
News
Company News
Blog
Careers
Contact Us
Catalog Peptides
US Operation
Email Us
Search
Search
Home
Catalog Peptides
Urocortins
Urocortins
UROC-001A
Urocortin, human
Asp-Asn-Pro-Ser-Leu-Ser-Ile-Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Thr-Leu-Leu-Glu-Leu-Ala-Arg-Thr-Gln-Ser-Gln-Arg-Glu-Arg-Ala-Glu-Gln-Asn-Arg-Ile-Ile-Phe-Asp-Ser-Val-NH2
UROC-001B
Urocortin, human
Asp-Asn-Pro-Ser-Leu-Ser-Ile-Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Thr-Leu-Leu-Glu-Leu-Ala-Arg-Thr-Gln-Ser-Gln-Arg-Glu-Arg-Ala-Glu-Gln-Asn-Arg-Ile-Ile-Phe-Asp-Ser-Val-NH2
UROC-002A
Urocortin, rat
Asp-Asp-Pro-Pro-Leu-Ser-Ile-Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Thr-Leu-Leu-Glu-Leu-Ala-Arg-Thr-Gln-Ser-Gln-Arg-Glu-Arg-Ala-Glu-Gln-Asn-Arg-Ile-Ile-Phe-Asp-Ser-Val-NH2
UROC-002B
Urocortin, rat
Asp-Asp-Pro-Pro-Leu-Ser-Ile-Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Thr-Leu-Leu-Glu-Leu-Ala-Arg-Thr-Gln-Ser-Gln-Arg-Glu-Arg-Ala-Glu-Gln-Asn-Arg-Ile-Ile-Phe-Asp-Ser-Val-NH2
UROC-003A
Urocortin II, human
Ile-Val-Leu-Ser-Leu-Asp-Val-Pro-Ile-Gly-Leu-Leu-Gln-Ile-Leu-Leu-Glu-Gln-Ala-Arg-Ala-Arg-Ala-Ala-Arg-Glu-Gln-Ala-Thr-Thr-Asn-Ala-Arg-Ile-Leu-Ala-Arg-Val-Gly-His-Cys-NH2
UROC-003B
Urocortin II, human
Ile-Val-Leu-Ser-Leu-Asp-Val-Pro-Ile-Gly-Leu-Leu-Gln-Ile-Leu-Leu-Glu-Gln-Ala-Arg-Ala-Arg-Ala-Ala-Arg-Glu-Gln-Ala-Thr-Thr-Asn-Ala-Arg-Ile-Leu-Ala-Arg-Val-Gly-His-Cys-NH2
UROC-004A
Urocortin III, human
Phe-Thr-Leu-Ser-Leu-Asp-Val-Pro-Thr-Asn-Ile-Met-Asn-Leu-Leu-Phe-Asn-Ile-Ala-Lys-Ala-Lys-Asn-Leu-Arg-Ala-Gln-Ala-Ala-Ala-Asn-Ala-His-Leu-Met-Ala-Gln-Ile-NH2
UROC-004B
Urocortin III, human
Phe-Thr-Leu-Ser-Leu-Asp-Val-Pro-Thr-Asn-Ile-Met-Asn-Leu-Leu-Phe-Asn-Ile-Ala-Lys-Ala-Lys-Asn-Leu-Arg-Ala-Gln-Ala-Ala-Ala-Asn-Ala-His-Leu-Met-Ala-Gln-Ile-NH2
UROC-005A
Urocortin II, mouse
Val-Ile-Leu-Ser-Leu-Asp-Val-Pro-Ile-Gly-Leu-Leu-Arg-Ile-Leu-Leu-Glu-Gln-Ala-Arg-Tyr-Lys-Ala-Ala-Arg-Asn-Gln-Ala-Ala-Thr-Asn-Ala-Gln-Ile-Leu-Ala-His-Val-NH2
UROC-005B
Urocortin II, mouse
Val-Ile-Leu-Ser-Leu-Asp-Val-Pro-Ile-Gly-Leu-Leu-Arg-Ile-Leu-Leu-Glu-Gln-Ala-Arg-Tyr-Lys-Ala-Ala-Arg-Asn-Gln-Ala-Ala-Thr-Asn-Ala-Gln-Ile-Leu-Ala-His-Val-NH2
UROC-006A
Urocortin III, mouse, free acid
Phe-Thr-Leu-Ser-Leu-Asp-Val-Pro-Thr-Asn-Ile-Met-Asn-Ile-Leu-Phe-Asn-Ile-Asp-Lys-Ala-Lys-Asn-Leu-Arg-Ala-Lys-Ala-Ala-Ala-Asn-Ala-Gln-Leu-Met-Ala-Gln-Ile
UROC-006B
Urocortin III, mouse, free acid
Phe-Thr-Leu-Ser-Leu-Asp-Val-Pro-Thr-Asn-Ile-Met-Asn-Ile-Leu-Phe-Asn-Ile-Asp-Lys-Ala-Lys-Asn-Leu-Arg-Ala-Lys-Ala-Ala-Ala-Asn-Ala-Gln-Leu-Met-Ala-Gln-Ile
UROC-007A
Urocortin III, mouse
Phe-Thr-Leu-Ser-Leu-Asp-Val-Pro-Thr-Asn-Ile-Met-Asn-Ile-Leu-Phe-Asn-Ile-Asp-Lys-Ala-Lys-Asn-Leu-Arg-Ala-Lys-Ala-Ala-Ala-Asn-Ala-Gln-Leu-Met-Ala-Gln-Ile-NH2
UROC-007B
Urocortin III, mouse
Phe-Thr-Leu-Ser-Leu-Asp-Val-Pro-Thr-Asn-Ile-Met-Asn-Ile-Leu-Phe-Asn-Ile-Asp-Lys-Ala-Lys-Asn-Leu-Arg-Ala-Lys-Ala-Ala-Ala-Asn-Ala-Gln-Leu-Met-Ala-Gln-Ile-NH2
Chinese Peptide Updates
30
Nov
2023
Emerging Trends in CGMP Peptide Manufacturing for Therapeutic Breakthroughs
Understanding the Importance of CGMP Peptides in Biopharmaceuticals
Nov 16, 2023
Exhibition review | Chinese Peptide company attended the 3rd China Polypeptide Industry Conference
Oct 11, 2023
The 8th CPC Symposiun on Peptide and Oligonucleotide Therapeutics was successfully concluded
Oct 10, 2023
86-571-86737011
Your browser does not support VBScript!
